Claims
- 1. An antibacterial compound of the formula (1), ##STR601## wherein R is a group represented by the formula, ##STR602## wherein R.sup.5 represents a conventional penicillin substituent selected from the group consisting of alkyl, cycloalkyl, cycloalkenyl, cycloalkadienyl, aryl, aralkyl, aryloxy, alkylthioalkyl, furyl, thienyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, imidazolyl, pyrazolyl, pyridyl, pyrazyl, pyrimidyl, pyridazyl, quinolyl, isoquinolyl, quinazolyl, indolyl, indazolyl, 1,3,4-oxadiazolyl, 1,2,4-oxadiazolyl, 1,3,4-thiadiazolyl and 1,2,4-thiadiazolyl, each of which may be substituted by halogen, hydroxy, nitro, alkyl, alkoxy, alkylthio, acyl or alkylsulfonylamino; R.sup.6 represents a hydrogen atom; and R.sup.5 and R.sup.6 together with a common carbon atom may form a conventional penicillin substituent selected from the group consisting of cycloalkyl, cycloalkenyl and cycloalkadienyl ring;
- R.sup.1 represents a hydrogen atom, a conventional penicillin blocking group of a conventional penicillin or a conventional salt-forming cation of a conventional penicillin; each pair of R.sup.2 and R.sup.3 are linked to the same carbon atom, and each R.sup.2 and R.sup.3 of the three pairs of R.sup.2 and R.sup.3, which may be the same or different, represent individually a conventional penicillin substituent selected from the group consisting of hydrogen, halogen, carboxyl, alkyl, cycloalkyl, aryl, acyl, aralkyl, alkoxycarbonylalkyl, acyloxyalkyl, alkoxy, alkoxycarbonyl, cycloalkyloxycarbonyl, aralkoxycarbonyl, aryloxycarbonyl, amino and carbamoyl; any of which may be substituted by halogen, alkyl, alkoxy, alkylthio, acyl or nitro; and any pair of R.sup.2 and R.sup.3 together with a common carbon atom may form a conventional penicillin substituent which is a cycloalkyl ring;
- A represents a conventional penicillin substituent selected from the group consisting of halogen, hydroxy, nitro, cyano, alkyl, alkenyl, alkadienyl, cycloalkyl, cycloalkenyl, cycloalkadienyl, aryl, acyl, aralkyl, acyloxyalkyl, alkoxy, cycloalkyloxy, alkoxycarbonyl, aryloxy, cycloalkyloxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, alkylsulfonyl, cycloalkylsulfonyl, arylsulfonyl, carbamoyl, thiocarbamoyl, acylcarbamoyl, acylthiocarbamoyl, alkylsulfonylcarbamoyl, arylsulfonylcarbamoyl, alkylsulfonylthiocarbamoyl, arylsulfonylthiocarbamoyl, sulfamoyl, alkoxycarbonylthioalkyl, alkoxythiocarbonylthioalkyl, amino, thiazolyl, pyridyl, pyridazyl, pyrazyl, thiadiazolyl, thiazolyl, tetrazolyl and quinolyl, each of which may be substituted by a conventional penicillin substitutent selected from the group consisting of halogen, hydroxyl, alkyl, alkoxy, alkylthio, nitro, cyano, amino, carboxyl, and acyl; and
- Y represents an oxygen or sulfur atom.
- 2. An antibacterial compound of claim 1, wherein A is a conventional penicillin substitutent selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, aryl and aralkyl, any of which may be substituted by halogen, hydroxyl, alkyl, alkoxy, alkylthio, nitro, cyano, amino, carboxyl or acyl; and R.sup.2 and R.sup.3 are individually hydrogen or alkyl.
- 3. An antibacterial compound of claim 1, wherein R.sup.1 is selected from the group consisting of ester-forming groups capable of being removed by catalytic reduction, chemical reduction or hydrolysis under mild conditions and ester-forming groups capable of being easily removed by enzymes in a living body.
- 4. An antibacterial compound of claim 1, wherein R.sup.1 is a cation capable of forming a non-toxic salt.
- 5. An antibacterial pharmaceutical composition comprising an antibacterially effective amount of a compound of claim 1 and a pharmaceutically acceptable carrier.
- 6. A method of combatting bacteria in mammals which comprises administering to said mammal an antibacterially effective amount of a compound of claim 1.
- 7. A compound of the formula (I), ##STR603## wherein R represents an .alpha.-amino acid residue represented by the formula, ##STR604## wherein R.sup.5 represents C.sub.1-18 alkyl, C.sub.5-7 cycloalkyl, C.sub.5-6 cycloalkenyl, C.sub.5-6 cycloalkadienyl, naphthyl, benzyl, phenethyl, phenoxy, naphthoxy, C.sub.1-2 alkylthio C.sub.1-2 alkyl, furyl, thienyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, imidazolyl, pyrazolyl, pyridyl, pyrazyl, pyrimidyl, pyridazyl, quinolyl, isoquinolyl, quinazolyl, indolyl, indazolyl, 1,3,4-oxadiazolyl, 1,2,4-oxadiazolyl, 1,3,4-thiadiazolyl, 1,2,4-thiadiazolyl, or phenyl, any of which may be optionally substituted by halogen, hydroxy, or nitro; R.sup.6 represents a hydrogen atom; or R.sup.5 and R.sup.6 together with a common carbon atom may form a C.sub.6-7 cycloalkyl, C.sub.5-6 cycloalkenyl or C.sub.5-6 cycloalkadienyl ring;
- R.sup.1 represents a hydrogen atom, a blocking group of a conventional penicillin or a salt-forming cation of a conventional penicillin; each pair of R.sup.2 and R.sup.3 are linked to the same carbon atom, and each R.sup.2 and R.sup.3 of the three pairs of R.sup.2 and R.sup.3, which may be the same or different, represent individually, hydrogen, halogen, carboxyl, C.sub.1-8 alkyl, C.sub.5-7 cycloalkyl, phenyl, naphthyl, acetyl, propionyl, butyryl, benzoyl, benzyl, phenethyl, C.sub.1-2 alkoxycarbonylmethyl, acetyloxymethyl, propionyloxymethyl, pivaloyloxymethyl, benzoyloxymethyl, C.sub.1-4 alkoxy, C.sub.1-3 alkoxycarbonyl, C.sub.5-7 cycloalkyloxycarbonyl, benzyloxycarbonyl, phenethoxycarbonyl, phenoxycarbonyl, naphthoxycarbonyl, amino, N-C.sub.1-4 alkylamino, N, N-di-C.sub.1-4 alkylamino, N-acetylamino, N-propionylamino, N-butyrylamino, N-benzoylamino, pyrrolidino, piperidino, morpholino, carbamoyl, N-methylaminocarbonyl, N-ethylaminocarbonyl, N,N-dimethylaminocarbonyl or N,N-diethylaminocarbonyl, any of which may be optionally substituted by halogen or nitro; or any pair of R.sup.2 and R.sup.3 together with a common carbon atom may form a C.sub.5-7 cycloalkyl ring;
- A represents hydrogen, hydroxy, nitro, cyano, C.sub.1-12 alkyl, C.sub.2-4 alkenyl, propargyl, C.sub.4-5 alkadienyl, C.sub.5-7 cycloalkyl, C.sub.5-6 cycloalkenyl, C.sub.5-6 cycloalkadienyl, phenyl, naphthyl, formyl, acetyl, propionyl, isovaleryl, caproyl, enanthoyl, capryloyl, palmitoyl, stearoyl, acryloyl, cyclohexanecarbonyl, benzoyl, phenylglycyl, furoyl, thenoyl, benzyl, phenethyl, acetyloxyethyl, pivaloyloxymethyl, benzoyloxymethyl, C.sub.1-4 alkoxy, C.sub.5-7 cycloalkyloxy, phenoxy, naphthoxy, C.sub.1-4 alkoxycarbonyl, C.sub.5-7 cycloalkyloxycarbonyl, phenoxycarbonyl, (1- or 2-) naphthoxycarbonyl, benzyloxycarbonyl, phenethoxycarbonyl, C.sub.1-4 alkylsulfonyl, C.sub.5-6 cycloalkylsulfonyl, benzenesulfonyl, (1- or 2-) naphthalenesulfonyl, carbamoyl, N-C.sub.1-4 alkylaminocarbonyl, N-phenylaminocarbonyl, N, N-di-C.sub.1-2 alkylaminocarbonyl, pyrrolidinocarbonyl, piperidinocarbonyl, morpholinocarbonyl, thiocarbamoyl, N-C-.sub.1-3 alkylaminothiocarbonyl, N-phenylaminothiocarbonyl, N,N-di-C.sub.1-2 alkylaminothiocarbonyl, pyrrolidinothiocarbonyl, piperidinothiocarbonyl, morpholinothiocarbonyl, N-acetylcarbamoyl, N-propionylcarbamoyl, N-butyrylcarbamoyl, N-benzoylcarbamoyl, N-furoylcarbamoyl, N-thenoylcarbamoyl, N-acetylthiocarbamoyl, N-propionylthiocarbamoyl, N-butyrylthiocarbamoyl, N-benzoylthiocarbamoyl, N-naphthoylthiocarbamoyl, N-furoylthiocarbamoyl, N-thenoylthiocarbamoyl, C.sub.1-4 alkylsulfonylcarbamoyl, benzenesulfonylamino-carbonyl, (1- or 2-) naphthalenesulfonylaminocarbonyl, C.sub.1-4 alkylsulfonylthiocarbamoyl, benzenesulfonylaminocarbonyl, naphthalenesulfonylaminothiocarbonyol, sulfamoyl, N-methylsulfamoyl, N-ethylsulfamoyl, N-propylsulfamoyl, N-butylsulfamoyl, N,N-dimethylsulfamoyl, N,N-diethylsulfamoyl, N,N-dipropylsulfamoyl,, N,N-dibutylsulfamoyl, N-phenylsulfamoyl, N-benzylsulfamoyl, N-cyclopentylsulfamoyl, N-cyclohexylsulfamoyl, C.sub.1-4 alkoxycarbonylthio C.sub.1-2 alkyl, C.sub.1-4 alkoxythiocarbonylthio C.sub.1-2 alkyl, amino C.sub.1-4 alkylamino, N,N-di-C.sub.1-4 alkylamino, N-acetylamino, N-propionylamino, N-butyrylamino, N-benzoylamino, pyrrolidino, piperidino, morpholino, thiazolyl, pyridyl, pyridazyl, pyrazyl, thiadiazolyl, triazolyl, tetrazolyl, or quinolyl, any of which may be optionally substituted by halogen, hydroxy, nitro, cyano, carboxyl, methoxy, or morpholino; and
- Y represents an oxygen or sulfur atom.
- 8. A compound of claim 7, wherein R.sup.5 represents C.sub.1-8 alkyl, C.sub.5-6 cycloalkadienyl, 2-thienyl or phenyl which may be optionally substituted by halogen, hydroxy or nitro; R.sup.6 is hydrogen; each pair of R.sup.2 and R.sup.3 are linked to the same carbon atom, and each R.sup.2 and R.sup.3 of the three pairs of R.sup.2 and R.sup.3, which may be the same or different, represent individually hydrogen, C.sub.1-8 alkyl, phenyl or C.sub.1-2 alkoxycarbonylmethyl or any pair of R.sup.2 and R.sup.3 together with a common carbon atom may form a C.sub.5-7 cycloalkyl ring; and
- A represents hydrogen, C.sub.1-12 alkyl, C.sub.2-4 alkenyl, C.sub.5-7 cycloalkyl, phenyl, formyl, acetyl, propionyl, isovaleryl, caproyl, enanthoyl, capryloyl, palmitoyl, stearoyl, cyclohexanecarbonyl, benzoyl, benzyl, acetyloxyethyl, pivaloyloxymethyl, C.sub.1-4 alkylsulfonyl, carbamoyl, N-acetylcarbamoyl, N-propionylcarbamoyl, N-butyrylcarbamoyl, N-phenylaminocarbonyl, or C.sub.1-4 alkoxycarbonyl, any of which may be optionally substituted by halogen, hydroxy, methoxy or morpholino.
- 9. A compound of claim 7, wherein R.sup.5 represents C.sub.1-8 alkyl, C.sub.5-6 cycloalkadienyl, 2-thienyl or phenyl, each of which may be optionally substituted by halogen, hydroxy or nitro; R.sup.6 represents a hydrogen atom; each pair of R.sup.2 and R.sup.3 are linked to the same carbon atom, and each R.sup.2 and R.sup.3 of the three pairs of R.sup.2 and R.sup.3, which may be the same or different, represent individually hydrogen, C.sub.1-8 alkyl or phenyl; and A represents hydrogen, C.sub.1-12 alkyl, C.sub.2-4 alkenyl, C.sub.5-7 cycloalkyl, phenyl, formyl, acetyl, propionyl, benzoyl, benzyl, acetyloxyethyl, pivaloyloxymethyl, C.sub.1-4 alkylsulfonyl, carbamoyl, N-acetylcarbamoyl, N-phenylaminocarbonyl or C.sub.1-4 alkoxycarbonyl, any of which may be optionally substituted by a halogen atom.
- 10. A compound of claim 7, wherein R.sup.5 represents C.sub.1-8 alkyl, C.sub.5-7 cycloalkyl, C.sub.5-6 cycloalkenyl, C.sub.5-6 cycloalkadienyl, naphthyl, benzyl, phenoxy, naphthoxy, C.sub.1-2 alkylthio C.sub.1-3 alkyl, furyl, thienyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, imidazolyl, pyrazolyl, pyridyl, pyrazyl, pyrimidyl, pyridazyl, quinolyl, isoquinolyl, quinazolyl, indolyl, indazolyl, 1,3,4-oxadiazolyl, 1,3,4-thiadiazolyl, 1,2,4-thiadiazolyl, or phenyl, any of which may be optionally substituted by halogen, hydroxy or nitro; R.sup.6 represents hydrogen; or R.sup.5 and R.sup.6 together with a common carbon atom may form a C.sub.6-7 cycloalkyl, C.sub.5-6 cycloalkenyl or C.sub.5-6 cycloalkadienyl ring; each pair of R.sup.2 and R.sup.3 are linked to the same carbon atom, and each R.sup.2 and R.sup.3 of the three pairs of R.sup.2 and R.sup.3, which may be the same or different, represent individually, hydrogen, halogen, carboxyl, C.sub.1-8 alkyl, phenyl, naphthyl, benzyl, C.sub.1-2 alkoxycarbonylmethyl, C.sub.1-3 alkoxycarbonyl, benzyloxycarbonyl, phenoxycarbonyl or carbamoyl, any of which may be optionally substituted by halogen or nitro; A represents hydrogen, C.sub.1-2 alkyl, C.sub.2-4 alkenyl, proparagyl, C.sub.5-7 cycloalkyl, phenyl, naphthyl, formyl, acetyl, propionyl, isovaleryl, caproyl, palmitoyl, stearoyl, acryloyl, benzoyl, phenylglycyl, furoyl, thenoyl, benzyl, pivaloyloxymethyl, C.sub.1-4 alkoxycarbonyl, C.sub.5-7 cycloalkyloxycarbonyl, phenoxycarbonyl, benzyloxycarbonyl, C.sub.1-4 alkylsulfonyl, C.sub.5-6 cycloalkylsulfonyl, benzenesulfonyl, carbamoyl, N-C.sub.1-4 alkylaminocarbonyl, N-phenylaminocarbonyl, N,N-di-C.sub.1-2 alkylaminocarbonyl, pyrrolidinocarbonyl, piperidinocarbonyl, morpholinocarbonyl, thiocarbamoyl, N-C.sub.1-3 alkylaminocarbonyl, pyrrolidinothiocarbonyl, piperidinothiocarbonyl, morpholinothiocarbonyl, N-acetylcarbamoyl, N-benzoylcarbamoyl, N-acetylthiocarbamoyl, N-benzoylthiocarbamoyl, C.sub.1-4 alkylsulfonylcarbamoyl, benzenesulfonylaminocarbonyl, C.sub.1-4 alkylsulfonylthiocarbamoyl, benzenesulfonylaminothiocarbonyl, sulfamoyl, N-methylsulfamoyl, N-ethylsulfamoyl, N,N-dimethylsulfamoyl, N-phenylsulfamoyl, N-benzenesulfamoyl, N-cyclohexylsulfamoyl, thiazolyl, pyridyl, pyridazyl or pyrazyl, any of which may be optionally substituted by halogen, hydroxy or nitro.
- 11. A compound of claim 10, wherein R.sup.5 represents a C.sub.1-8 alkyl, C.sub.5-6 cycloalkadienyl, thienyl or phenyl, any of which may be optionally substituted by halogen, hydroxy or nitro; R.sup.6 represents a hydrogen atom; A is hydrogen, C.sub.1-12 alkyl, C.sub.2-4 alkenyl, phenyl or benzyl, each of which may be optionally substituted by halogen; each pair of R.sup.2 and R.sup.3 are linked to the same carbon atom, and each R.sup.2 and R.sup.3 of the trace pairs of R.sup.2 and R.sup.3, which may be the same or different, are individually hydrogen or C.sub.1-8 alkyl; and R.sup.1 is a hydrogen atom, a cation capable of forming a non-toxic salt or an ester-forming group capable of being easily removed by enzymes in a living body.
- 12. A compound of the formula (I), ##STR605## wherein R represents an .alpha.-amino acid residue represented by the formula ##STR606## wherein R.sup.5 represents C.sub.1-18 alkyl, C.sub.5-7 cycloalkenyl, C.sub.5-6 cycloalkadienyl, naphthyl, benzyl, phenoxy, naphthoxy, C.sub.1-2 alkylthio C.sub.1-2 alkyl, furyl, thienyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, imidazolyl, pyrazolyl, pyridyl, pyrazyl, pyrimidyl, pyridazyl, quinolyl, isoquinolyl, quinazolyl, indolyl, indazolyl, 1,3,4-oxadiazolyl, 1,3,4-thiadiazolyl, 1,2,4-thiadiazolyl, or phenyl, any of which may be optionally substituted by halogen, hydroxy or nitro; R.sup.6 represents a hydrogen atom; or R.sup.5 and R.sup.6 together with a common atom may form a C.sub.6-7 cycloalkyl, C.sub.5-6 cycloalkenyl or C.sub.5-6 cycloalkadienyl ring;
- R.sup.1 represents a hydrogen atom, a blocking group of a conventional penicillin or a salt-forming cation of a conventional penicillin; each pair of R.sup.2 and R.sup.3 are linked to the same carbon atom, and each R.sup.2 and R.sup.3 of the three pairs of R.sup.2 and R.sup.3, which may be the same or different, represent individually, hydrogen, halogen, carboxyl, C.sub.1-8 alkyl, C.sub.5-7 cycloalkyl, phenyl, napthyl, acetyl, benzoyl, benzyl, C.sub.1-2 alkoxycarbonyl-methyl, acetyloxymethyl, pivaloyloxymethyl, C.sub.1-4 alkoxy, C.sub.1-3 alkoxycarbonyl, C.sub.5-7 cycloalkyloxycarbonyl, benzyloxycarbonyl, phenoxycarbonyl, amino, N-C.sub.1-4 alkylamine, N,N-di-C.sub.1-4 alkylamino, N-acetylamino or carbamoyl, any of which may be optionally substituted by halogen or nitro, or any pair of R.sup.2 and R.sup.3 together with a common carbon atom may form a C.sub.5-7 cycloalkyl ring;
- A represents hydrogen, hydroxy, nitro, cyano, C.sub.1-12 alkyl, C.sub.2-4 alkenyl, propargyl, C.sub.4-5 cycloalkyl, C.sub.5-6 cycloalkenyl, C.sub.5-6 cycloalkadienyl, phenyl, naphthyl, formyl, acetyl, propionyl, isovaleryl, caproyl, palmitoyl, stearoyl, acryloyl, benzoyl, phenylglycyl, furoyl, thenoyl, benzyl, pivaloyloxymethyl, C.sub.1-4 alkoxy, C.sub.5-7 cycloalkyloxy, phenoxy, naphthoxy, C.sub.1-4 alkoxycarbonyl, C.sub.5-7 cycloalkyloxycarbonyl, phenoxycarbonyl, benzyloxycarbonyl, C.sub.1-4 alkylsulfonyl, C.sub.5-6 cycloalkylsulfonyl, benzenesulfonyl, carbamoyl, N-C.sub.1-4 alkylaminocarbonyl, N-phenylaminocarbonyl, N,N-di-C.sub.1-2 alkylaminocarbonyl, pyrrolidinocarbonyl, piperdinocarbonyl, morpholinocarbonyl, thiocarbamoyl, N-C.sub.1-3 alkylaminothiocarbonyl, N-phenylaminothiocarbonyl, N,N-di-C.sub.1-2 alkylaminothiocarbonyl, pyrrolidinothiocarbonyl, piperidinothiocarbonyl, morpholinothiocarbonyl, N-acetylcarbamoyl, N-benzoylcarbamoyl, N-furoylcarbamoyl, N-acetylthiocarbamoyl, N-benzoylthiocarbamoyl, C.sub.1-4 alkylsulfonylcarbamoyl, benzenesulfonylaminocarbonyl, C.sub.1-4 alkylsulfonylthiocarbamoyl, benzenesulfonylaminothiocarbonyl, sulfamoyl, N-methylsulfamoyl, N-ethylsulfamoyl, N,N-dimethylsulfamoyl, N-phenylsulfamoyl, N-benzylsulfamoyl, N-cyclohexylsulfamoyl, amino, C.sub.1-4 alkylamino, N,N-di-C.sub.1-4 alkylamino, N-acetylamino, thiazolyl, pyridyl, pyridazyl or pyrazyl, any of which may be optionally substituted by halogen, hydroxy, nitro, cyano, carboxyl, methoxy or morpholino; and
- Y represents an oxygen or sulfur atom.
- 13. A compound of the formula (I), ##STR607## wherein R represents an .alpha.-amino acid residue represented by the formula, ##STR608## wherein R.sup.5 represents C.sub.1-8 alkyl, C.sub.5-7 cycloalkyl, C.sub.5-6 cycloalkenyl, C.sub.5-6 cycloalkadienyl, naphthyl, benzyl, phenoxy, napthoxy, furyl, thienyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, imidazolyl, pyrazolyl, pyridyl, pyrazyl, pyrimidyl, pyridazyl, quinolyl, isoquinolyl, quinazolyl, indolyl, indazolyl, 1,2,4-oxadiazolyl, 1,3,4-thiadiazolyl, 1,2,4-thiadiazolyl or phenyl, any of which may be optionally substituted by halogen, hydroxy or nitro; R.sup.6 represents a hydrogen atom; or R.sup.5 and R.sup.6 together with a common carbon atom may form a C.sub.6-7 cycloalkyl C.sub.5-6 cycloalkenyl or C.sub.5-6 cycloalkadienyl ring;
- R.sup.1 represents a hydrogen atom, a blocking group of a conventional penicillin or a salt-forming cation of a conventional penicillin; each pair of R.sup.2 and R.sup.3 are the three pairs of R.sup.2 and R.sup.3, which may be the same or different, represent individually hydrogen, halogen, carboxyl, C.sub.1-18 alkyl, phenyl, naphthyl, benzyl, C.sub.1-3 alkoxycarbonyl, benzyloxycarbonyl, phenoxycarbonyl or carbamoyl, any of which may be optionally substituted by halogen or nitro;
- A represents hydrogen, C.sub.1-12 alkyl, C.sub.2-4 alkenyl, propargyl, C.sub.5-7 cycloalkyl, phenyl, naphthyl, formyl, acetyl, propionyl, benzoyl, furoyl, thenoyl, benzyl, pivaloyloxymethyl, C.sub.1-4 alkoxycarbonyl, C.sub.5-7 cycloalkyloxycarbonyl, phenoxycarbonyl, benzyloxycarbonyl, C.sub.1-4 alkylsulfonyl, C.sub.5-6 cycloalksulfonyl, benzenesulfonyl, carbamoyl, N-C.sub.1-4 alkylaminocarbonyl, N-phenylaminocarbonyl, N,N-di-C.sub.1-2 alkylaminocarbonyl, pyrrolidinocarbonyl, piperidinocarbonyl, thiocarbamoyl, N-C.sub.1-3 alkylaminothiocarbonyl, pyrrolidinothiocarbonyl, piperidinothiocarbonyl, N-acetylcarbamoyl, N-acetylthiocarbamoyl, C.sub.1-4 alkylsulfonylcarbamoyl, C.sub.1-4 alkylsulfonthiocarbamoyl, sulfamoyl, N-methylsulfamoyl, N-ethylsulfamoyl, N,N-dimethylsulfamoyl, N-phenylsulfamoyl, N-cyclohexylsulfamoyl, thiazolyl, pyridyl, pyridazyl or pyrazyl, any of which may be optionally substituted by halogen or nitro; and
- Y represents an oxygen or sulfur atom.
- 14. A compound selected from the group consisting of 6-[D(-)-.alpha.-(4-methyl-3-oxo-1-piperazinocarbonylamino)-phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-n-butyl-3-oxo-1-piperzinocarbonylamino)-phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-ethyl-3-oxo-1-piperazinocarbonylamino)-phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-isopropyl-3-oxo-1-piperazinocarbonyl-amino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-n-pentyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-iso-pentyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido]penicillanic acid,
- 6-[D(-)-.alpha.-(2-methyl-4-n-butyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-n-butyl-5-methyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4n-butyl-6-methyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-benzyl-3-oxo-1-piperazinocarbonylamino)-phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-.beta.-hydroxyethyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-acetyl-2-methyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-carbamoyl-2-methyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[(-)-.alpha.-(3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(2,5-dimethyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(5-methyl-3-oxo-1-piperazinocarbonylamino)-phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(2-ethoxycarbonylmethyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(2-methyl-3-oxo-1-piperazinocarbonylamino)-phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-ethyl-3-oxo-1-piperazinocarbonylamino)-propionamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-allyl-3-oxo-1-piperazinocarbonylamino)-phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-.alpha.-methylallyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-.beta.-methylallyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-[4-(trans-2-butenyl)-3-oxo-1-piperazinocarbonylamino]phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-n-hexyl-3-oxo-1-piperazinocarbonylamino] phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-n-heptyl-3-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-n-octyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-n-dodecyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-cyclopentyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(4-phenylaminocarbonyl-3-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid,
- 6-[D(-)-.alpha.-(2-phenyl-3-oxo-1-piperazinocarbonylamino)-phenylacetamido] penicillanic acid, and
- 6-[D(-)-.alpha.-(4-morpholinomethyl-3-oxo-1-piperazinocarbonylamino)phenylacetamido] penicillanic acid.
Priority Claims (7)
| Number |
Date |
Country |
Kind |
| 49-50663 |
May 1974 |
JPX |
|
| 49-52254 |
May 1974 |
JPX |
|
| 49-60787 |
May 1974 |
JPX |
|
| 49-91996 |
Aug 1974 |
JPX |
|
| 49-109954 |
Sep 1974 |
JPX |
|
| 49-142499 |
Dec 1974 |
JPX |
|
| 50-37207 |
Mar 1975 |
JPX |
|
CROSS REFERENCES TO RELATED APPLICATIONS
This application is a Divisional of Ser. No. 915,873, filed June 15, 1978, now U.S. Pat. No. 4,219,554, which itself is a Division of Ser. No. 654,060, filed Jan. 30, 1976, now U.S. Pat. No. 4,112,090 which is in turn a continuation-in-part of Ser. No. 571,479, filed Apr. 24, 1975, now U.S. Pat. No. 4,087,424.
US Referenced Citations (3)
| Number |
Name |
Date |
Kind |
|
3939150 |
Murakami et al. |
Feb 1976 |
|
|
3959258 |
Konig et al. |
May 1976 |
|
|
3983105 |
Konig et al. |
Sep 1976 |
|
Divisions (2)
|
Number |
Date |
Country |
| Parent |
915873 |
Jun 1978 |
|
| Parent |
654060 |
Jan 1976 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
| Parent |
571479 |
Apr 1975 |
|
Patent Grant
4327097
